Disease | hartnup disease |
Comorbidity | C0023470|myelogenous leukemia |
Sentences | 1 |
PubMedID- 23289360 | The bcr-abl1 t315i mutation and additional genomic aberrations are dominant genetic lesions associated with disease progression in patients with chronic myelogenous leukemia resistant to tyrosine kinase inhibitor therapy. |
Page: 1